A single sublingual dose of an adenovirus-based vaccine protects against lethal Ebola challenge in mice and guinea pigs.
about
Current ebola vaccinesEmerging targets and novel approaches to Ebola virus prophylaxis and treatmentEbola virus vaccines: an overview of current approachesEffect of vaccine administration modality on immunogenicity and efficacy.Sublingual vaccination induces mucosal and systemic adaptive immunity for protection against lung tumor challenge.Development of safe and effective RSV vaccine by modified CD4 epitope in G protein core fragment (Gcf).Bolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola VaccineA Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola InfectionPotential vaccines and post-exposure treatments for filovirus infections.Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola.Intra-cheek immunization as a novel vaccination route for therapeutic vaccines of head and neck squamous cell carcinomas using plasmo virus-like particles.Modeling pre-existing immunity to adenovirus in rodents: immunological requirements for successful development of a recombinant adenovirus serotype 5-based ebola vaccine.Dendritic cells of the oral mucosa.Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature.Adenoviral vector-based strategies against infectious disease and cancer.Ebola virus vaccines - reality or fiction?A Sensitive in Vitro High-Throughput Screen To Identify Pan-filoviral Replication Inhibitors Targeting the VP35-NP Interface.Optimization of Prime-Boost Vaccination Strategies Against Mouse-Adapted Ebolavirus in a Short-Term Protection Study.Challenges, progress, and opportunities: proceedings of the filovirus medical countermeasures workshop.
P2860
Q21534720-9DE06B08-F209-4008-970C-4F4A5D276C39Q24597625-93D52D7C-17DA-463D-9195-630EA7CF6682Q26999232-E6D6EE2C-EAF9-4AB7-80B7-8684144EF063Q27692376-3C7074F0-89D0-4B77-A9B5-05BB44580BD7Q31153121-BB852746-595C-474B-A8B8-73EC0A0DDCFDQ35149594-73AF11A7-392A-4DD5-A70B-6A35F5FCE8ECQ35917496-3899196A-D8AA-4DAD-9C3F-DD920FB381B1Q35917501-6872A4A6-9734-4BB9-AC0D-4A3FF7984450Q36404178-775B7DDD-85BB-49B6-B00C-3A4DA5616F53Q36995725-33779EA8-3634-4B26-BC5E-C39364D3501FQ37222100-6DE9F927-C8F9-40EA-AE3A-93169B6D8260Q37627897-57F23662-B2DC-47F3-BAF1-9A708A2456A1Q38113759-372EAF45-688C-4160-B334-22088A0FA75FQ38186768-882A0A8D-C6F4-4BA2-886E-9398A2D8838BQ38814885-D5295C62-B8E3-4286-A927-C6C7BBE0BCB4Q38881265-2A6448BC-1157-49F2-B5D2-6A4F90716A94Q40070709-C43F2B75-8E13-4CEA-B7FD-0FEB8AAB335DQ40153269-2A117265-58ED-4E32-A89E-A1A55A04E09DQ42753196-5BED90C4-0D2B-42D2-BAD2-F7A978CE4613
P2860
A single sublingual dose of an adenovirus-based vaccine protects against lethal Ebola challenge in mice and guinea pigs.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A single sublingual dose of an ...... lenge in mice and guinea pigs.
@ast
A single sublingual dose of an ...... lenge in mice and guinea pigs.
@en
type
label
A single sublingual dose of an ...... lenge in mice and guinea pigs.
@ast
A single sublingual dose of an ...... lenge in mice and guinea pigs.
@en
prefLabel
A single sublingual dose of an ...... lenge in mice and guinea pigs.
@ast
A single sublingual dose of an ...... lenge in mice and guinea pigs.
@en
P2093
P2860
P921
P356
P1476
A single sublingual dose of an ...... lenge in mice and guinea pigs.
@en
P2093
Alexander N Freiberg
Jin Huk Choi
Lihong Zhang
Maria A Croyle
Stephen C Schafer
Terry Juelich
P2860
P304
P356
10.1021/MP200392G
P407
P577
2011-12-15T00:00:00Z